Waqas Gilani, MD
Neurology Physician in Sherman, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 19,885 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Waqas Gilani, MD reported a CMS MIPS final score of 93.1/100 - above the 83.1 national average - and filed 3,965 Medicare Part D claims in 2023.
- 93.1/100
- MIPS score · +10 vs avg
- 4K
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Waqas Gilani, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
93 Top 29% higher than 71% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Waqas Gilani, MD sits
This provider among neurology physician peers
Across the 5,437 neurology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Waqas Gilani, MD writes more Part D claims than 89% of them and scores higher on MIPS quality than 73% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neurology physician peer from a representative sample of 60; the gold marker is Waqas Gilani, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Waqas Gilani, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Waqas Gilani, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Neurology Physician compares to other specialties among Texas providers
Neurology Physician ranks #53 among Texas's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Neurology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Waqas Gilani, MD's 2023 MIPS final score plotted against the Neurology Physician national average
- MIPS Final Score
- 93.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neurology Physician) - 93.1/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Neurology Physician US NPIs
93.1/100 MIPS final score - 10.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Neurology Physician. Quality dim: 83.1.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Waqas Gilani, MD appears in the CMS NPPES registry as a Neurology Physician provider holding MD credentials at 321 N HIGHLAND AVE STE 200, Sherman, TX, 75092, with a listed phone of (903) 903-5141. NPI 1386039683 was issued on 04/02/2015.
Medicare Part D records for calendar year 2023 show 3,965 prescription claims written by this provider, covering 617 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, split 13% brand-name and 86% generic by claim count, with an opioid prescribing rate of 0.3%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.1/100 for the 2023 performance year (Quality 83.1), compared with the national average of 83.1.
Neurology Physician is a mid-sized specialty nationwide, with 19,885 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1386039683 |
|---|---|
| Specialty | Neurology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/02/2015 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Waqas Gilani, MD's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1386039683 is the unique 10-digit identifier CMS uses to link Gilani across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Waqas Gilani, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Waqas Gilani, MD is affiliated with 3 Medicare-billing facilities across 2 states.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Waqas Gilani, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.5K
Largest payer
Biogen, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Waqas Gilani, MD. To verify Waqas Gilani, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 86% generic, on 3,965 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,658
- Total Day Supply
- 190,518
- Brand vs Generic
- 13% brand / 86% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $225K
- Opioid Claims
- 13 (0.3% rate)
Patient Demographics
- Average Patient Age
- 65.3 years
- Avg HCC Risk Score
- 1.67
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 250, 65-74: 184, 75-84: 156, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Waqas Gilani, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
317 claims
- Levetiracetam
Levetiracetam
215 claims
- Carbidopa-Levodopa
Carbidopa-Levodopa
198 claims
- Lamotrigine 123
Lamotrigine
123 claims
- Tizanidine Hcl 108
Tizanidine Hcl
108 claims
- Baclofen 107
Baclofen
107 claims
- Donepezil Hcl 105
Donepezil Hcl
105 claims
- Topiramate 100
Topiramate
100 claims
| Drug | Claims |
|---|---|
| Gabapentin | 317 |
| Levetiracetam | 215 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 198 |
| Lamotrigine | 123 |
| Tizanidine Hcl | 108 |
| Baclofen | 107 |
| Donepezil Hcl | 105 |
| Topiramate | 100 |
| Cyclobenzaprine Hcl | 98 |
| Sumatriptan Succinate | 92 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology Physician Overview
How Waqas Gilani, MD fits within the Neurology Physician landscape nationally.
Waqas Gilani, MD's 3,965 claims are above the specialty average of 1,309.
Nearby Neurology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Gilani.
Compare Neurology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neurology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Waqas Gilani, MD's specialty? ▼
How much does Waqas Gilani, MD prescribe under Medicare Part D? ▼
What is Waqas Gilani, MD's Medicare quality score? ▼
Where is Waqas Gilani, MD located? ▼
What is Waqas Gilani, MD's NPI number? ▼
Does Waqas Gilani, MD prescribe more brand-name or generic drugs? ▼
Does Waqas Gilani, MD prescribe opioids? ▼
How many Neurology Physician providers are there in the US? ▼
What drugs does Waqas Gilani, MD prescribe most often? ▼
Does Waqas Gilani, MD accept Medicare? ▼
How can I verify Waqas Gilani, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.